F.D.A. Expands Access to Clozapine, a Key Treatment for Schizophrenia

Health
By Ellen Barry from NYT Health https://ift.tt/DsExhWI
via IFTTT Regulation and Deregulation of Industry, Tests (Medical), Schizophrenia, Drugs (Pharmaceuticals), Mental Health and Disorders, your-feed-science, your-feed-healthcare Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda